构建国际医学合作的“防城港渠道”

Core Insights - The establishment of the Fangchenggang International Medical Open Experimental Zone is aimed at promoting international medical innovation cooperation and building a global health community, as initiated by President Xi Jinping in 2019 [1][2] - The zone has made significant progress in international medical exchanges and cooperation, signing memorandums with foreign parks and hosting numerous international forums [2][3] - The China-ASEAN Regional Pharmaceutical Trading Platform has been launched, facilitating cross-border transactions and supporting Chinese pharmaceutical companies in entering ASEAN markets [4][5] Group 1: International Cooperation and Development - The Fangchenggang International Medical Open Experimental Zone has signed cooperation memorandums with three foreign parks, including Uzbekistan and Pakistan, and has established partnerships for traditional medicine and medical device trade [2] - The zone has hosted over 10 international medical forums, with participation from over 630 officials and experts from 39 countries, resulting in the release of key documents like the "Fangchenggang Declaration" [3] - The zone has actively engaged in international exchanges, sending 209 delegations to 28 countries and collaborating with 11 international sister cities [3] Group 2: Platform and Infrastructure Development - The China-ASEAN Regional Pharmaceutical Trading Platform has been officially launched, featuring 781 types of drugs and 1,652 categories of medical supplies, with participation from 114 Chinese pharmaceutical companies [4] - The platform aims to provide a comprehensive process for cross-border transactions, enhancing the efficiency and safety of medical product exchanges [4] - The establishment of various major platforms, including a national food safety and nutrition innovation platform and a key laboratory for bioactive molecules, has been prioritized to accelerate innovation [5] Group 3: Investment and Financial Initiatives - A QFLP fund with a total scale of 500 million yuan has been established in collaboration with Singapore's UOB, with 200 million yuan already contributed [5] - The Fangchenggang International Medical Open Experimental Zone has seen a significant increase in registered medical device products, from 3 in 2019 to 165 currently, with 37 medical device companies operating in the area [5]